Ellington Management Group’s Core Laboratories CLB Stock Holding History

Ellington Management Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,600	Closed	-$285K	–	837
2017 Q4	$285K	Sell	2,600 -800	-24%	-$79.8K	0.05%	382
2017 Q3	$336K	Sell	3,400 -1,000	-23%	-$96.9K	0.06%	347
2017 Q2	$446K	Buy	+4,400	New	+$474K	0.06%	276
2016 Q4	–	Sell	-1,900	Closed	-$213K	–	573
2016 Q3	$213K	Hold	1,900	–	–	0.06%	522
2016 Q2	$235K	Sell	1,900 -100	-5%	-$12.1K	0.33%	102
2016 Q1	$225K	Sell	2,000 -800	-29%	-$83.1K	0.1%	333
2015 Q4	$304K	Buy	+2,800	New	+$321K	0.11%	276

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Ellington Management Group's CLB Position: Q1 2018 in Review

Ellington Management Group sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 2,600 shares — an estimated $285K sold.

Ellington Management Group first reported a position in CLB in Q4 2015 and held it in 7 quarters. The position peaked at $446K in Q2 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

Ellington Management Group reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
Ellington Management Group sold 2,600 Core Laboratories shares in Q1 2018, an estimated $285K.
Ellington Management Group first reported a position in Core Laboratories in Q4 2015 and held it in 7 quarters.
Ellington Management Group's Core Laboratories position peaked at $446K in Q2 2017.
355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Ellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.